Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

By A. Bartholomew, Cord Sturgeon, Mandy Siatskas, K. Ferrer, K. Mcintosh, S. Patil, Wayne Hardy, S. Devine, D. Ucker, R. Deans and 2 more. Experimental Hematology, 2002

2,335 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0db67a678790e6d50f4da19e774d701b2c363404

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. O. Ringdén
2. Frank Barry
3. C. Gregory
4. Jeffrey L Spees
5. R. Lee
6. A. Caplan
7. W. Fibbe

In Molecular Biology

1. Hanns-Ulrich Marschall
2. C. Gregory
3. Jeffrey L Spees
4. R. Lee

Citations in the corpus

• Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications (2005, background): “Finally, we explored whether MSCs expanded in PL medium retained their immunosuppressive capacity as demonstrated by recent studies (Bartholomew et al., 2002; Di Nicola et al., 2002; Djouad et al., 2003).”
• Mesenchymal stem cells avoid allogeneic rejection (2005, background): “This supported work from Bartholomew et al showing that the addition of IL-2 to MLR/ MSC co-cultures reduced MSC suppression and restored T cell proliferation[19].”
• T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. (2005, background): “This is supported by preliminary results from ongoing clinical trials [37, 38] and a skin graft study in baboons [ 18 ].”